光線力学療法（PDT）市場規模、シェア、成長分析、メカニズム別、カテゴリー別、治療法別、ソフトウェア別、サービス別、アプリアクセシビリティ別、用途別、地域別 - 産業予測、2025年～2032年

光線力学療法（PDT）の世界市場規模は2023年に41億米ドルと評価され、2024年の49億3,000万米ドルから2032年には216億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは20.3％で成長する見通しです。

世界の調査手法は、従来の方法論を超越した個別化された有効性重視の治療ソリューションに対する需要によってますます影響を受けています。このシフトは、カスタマイズされた治療プログラムが患者の関与と臨床結果を強化し、従来の薬理学的アプローチへの依存を最小限に抑えるという認識の高まりから生じています。PDTを標準的な治療ルーチンに組み込むことは、規制当局によって確立されたより明確な承認経路によって促進され、普及しつつあります。さらに、慢性疾患と行動的健康状態の管理におけるPDTの価値を認識する保険プロバイダーも増えており、ハイテク企業、ヘルスケアプロバイダー、ライフサイエンス企業間の協力的な取り組みが推進されています。主な動向としては、臨床検証の重視、デジタルヘルスイノベーターと既存のヘルスケア事業体とのパートナーシップ、強固で患者に焦点を当てた治療を保証するためのデータプライバシーとセキュリティに関する重要な懸念への対応などが挙げられます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• ケーススタディ
• 顧客購買行動分析

光線力学療法（PDT）市場規模：メカニズム別& CAGR（2025-2032）

• 市場概要
• 入力メカニズム
• 出力メカニズム

光線力学療法（PDT）市場規模：カテゴリー別& CAGR（2025-2032）

• 市場概要
• 薬物増強
• 薬の代替

光線力学療法（PDT）市場規模：治療法別& CAGR（2025-2032）

• 市場概要
• 外来治療
• 単剤療法

光線力学療法（PDT）市場規模：ソフトウェア別& CAGR（2025-2032）

• 市場概要
• 呼吸器疾患向けソフトウェア
• メンタルヘルスのためのソフトウェア
• オピオイド使用障害のためのソフトウェア
• 糖尿病のためのソフトウェア
• その他

光線力学療法（PDT）市場規模：サービス別& CAGR（2025-2032）

• 市場概要
• 行動マイクロサービス
• 医療マイクロサービス

光線力学療法（PDT）市場規模：アプリのアクセシビリティ別& CAGR（2025-2032）

• 市場概要
• Android
• iOS
• Windows

光線力学療法（PDT）市場規模：アプリの種類別& CAGR（2025-2032）

• 市場概要
• ネイティブアプリ
• ウェブアプリ

光線力学療法（PDT）市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 物質使用障害（SUD）
• オピオイド使用障害（OUD）
• 注意欠陥・多動性障害（ADHD）
• アルツハイマー病
• 大うつ病性障害（MDD）
• 不眠症
• てんかん
• 運動障害
• 多発性硬化症
• 片頭痛
• 自閉症スペクトラム障害
• 腫瘍学
• 炎症
• 呼吸器
• 心血管系
• 疼痛管理
• 代謝状態
• その他

光線力学療法（PDT）市場規模：患者別& CAGR（2025-2032）

• 市場概要
• 子供
• 大人

光線力学療法（PDT）市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• ResMed（US）
• SAMSUNGHEALTHCARE（South Korea）
• Novartis AG（Switzerland）
• Medtronic（Ireland）
• Omada Health, Inc.（US）
• GAIA AG（Germany）
• Welldoc's Bluestar（US）
• Better Therapeutics, LLC（US）
• BigHealth（US）
• Biofourmis（US）
• Click Therapeutics, Inc.（US）
• Happify, Inc.（US）
• Naturalcycles Nordic AB（Sweden）
• NuvoAir AB（Sweden）
• Sensyne Health plc.（UK）

結論と提言

Global Photodynamic Therapy (PDT) Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.93 billion in 2024 to USD 21.64 billion by 2032, growing at a CAGR of 20.3% during the forecast period (2025-2032).

The global Photodynamic Therapy (PDT) landscape is increasingly influenced by the demand for personalized and efficacy-driven treatment solutions that transcend conventional methodologies. This shift stems from a growing acknowledgment that customized therapeutic programs enhance patient engagement and clinical results, minimizing dependence on traditional pharmacological approaches. Integration of PDT into standard care routines is becoming prevalent, facilitated by clearer approval pathways established by regulatory agencies. Additionally, insurance providers are increasingly recognizing the value of PDT in managing both chronic and behavioral health conditions, driving collaborative efforts among tech companies, healthcare providers, and life-science firms. Key trends include a focus on clinical validation and partnerships between digital health innovators and established healthcare entities, addressing critical concerns around data privacy and security to ensure robust, patient-focused therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Photodynamic Therapy (PDT) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Photodynamic Therapy (PDT) Market Segments Analysis

Global Photodynamic Therapy (PDT) Market is segmented by Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients and region. Based on Mechanism, the market is segmented into Input Mechanisms and Output Mechanisms. Based on Category, the market is segmented into Medication Augmentation and Medication Replacement. Based on Treatment, the market is segmented into Outpatient Treatment and Monotherapy. Based on Software, the market is segmented into Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes and Others. Based on Services, the market is segmented into Behavioral Microservices and Medical Microservices. Based on App Accessibility, the market is segmented into Android, iOS and Windows. Based on App Type, the market is segmented into Native Apps and Web Apps. Based on Application, the market is segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer's Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions and Others. Based on Patients, the market is segmented into Children and Adults. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Photodynamic Therapy (PDT) Market

The increasing focus on patient-centric care is significantly driving growth in the global Photodynamic Therapy (PDT) market. There is a heightened demand for therapeutic solutions that prioritize personalized support rather than relying solely on traditional medications. Prescription digital therapeutics are gaining traction, offering structured and evidence-based programs that can be tailored to the unique requirements of each patient. This evolution is particularly essential for the management of chronic and behavioral health issues, where ongoing engagement and real-time feedback play a crucial role. As patients' expectations shift, the attractiveness of customized, technology-driven treatment options continues to expand.

Restraints in the Global Photodynamic Therapy (PDT) Market

Despite the increasing interest in photodynamic therapy (PDT), there is still a significant lack of awareness among healthcare providers and patients regarding its clinical benefits and accessibility. This unfamiliarity contributes to reluctance in adopting PDT, resulting in lower prescription rates. Furthermore, the available training and educational resources are insufficient, hindering the integration of PDT into standard treatment practices. Without a deeper understanding among key stakeholders, the market potential for PDT remains largely untapped, as misconceptions and a lack of knowledge impede its acceptance and implementation in therapeutic settings.

Market Trends of the Global Photodynamic Therapy (PDT) Market

The Global Photodynamic Therapy (PDT) market is experiencing a transformative trend driven by the integration of drug-digital combination therapies. Pharmaceutical companies are forging partnerships with digital therapeutic developers to create innovative solutions that combine PDT with software-based interventions. This synergistic approach enhances treatment efficacy by modifying both patient behavior and pharmacological responses simultaneously. The incorporation of digital tools not only aids in adherence tracking but also facilitates the collection of real-world data, leading to improved therapeutic outcomes. As the demand for personalized medicine and enhanced patient care continues to rise, the PDT market is poised for significant growth, characterized by this collaborative evolution.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Photodynamic Therapy (PDT) Market Size by Mechanism & CAGR (2025-2032)

• Market Overview
• Input Mechanisms
• Output Mechanisms

Global Photodynamic Therapy (PDT) Market Size by Category & CAGR (2025-2032)

• Market Overview
• Medication Augmentation
• Medication Replacement

Global Photodynamic Therapy (PDT) Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Outpatient Treatment
• Monotherapy

Global Photodynamic Therapy (PDT) Market Size by Software & CAGR (2025-2032)

• Market Overview
• Software for Respiratory Conditions
• Software for Mental Health
• Software for Opioid Use Disorder
• Software for Diabetes
• Others

Global Photodynamic Therapy (PDT) Market Size by Services & CAGR (2025-2032)

• Market Overview
• Behavioral Microservices
• Medical Microservices

Global Photodynamic Therapy (PDT) Market Size by App Accessibility & CAGR (2025-2032)

• Market Overview
• Android
• iOS
• Windows

Global Photodynamic Therapy (PDT) Market Size by App Type & CAGR (2025-2032)

• Market Overview
• Native Apps
• Web Apps

Global Photodynamic Therapy (PDT) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Substance Use Disorder (SUD)
• Opioid Use Disorder (OUD)
• Attention Deficit/Hyperactivity Disorder (ADHD)
• Alzheimer's Disease
• Major Depressive Disorder (MDD)
• Insomnia
• Epilepsy
• Movement Disorder
• Multiple Sclerosis
• Migraine
• Autism Spectrum Disorder
• Oncology
• Inflammation
• Respiratory
• Cardiovascular
• Pain Management
• Metabolic Conditions
• Others

Global Photodynamic Therapy (PDT) Market Size by Patients & CAGR (2025-2032)

• Market Overview
• Children
• Adults

Global Photodynamic Therapy (PDT) Market Size & CAGR (2025-2032)

• North America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • US
  • Canada
• Europe (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ResMed (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAMSUNGHEALTHCARE (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GAIA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welldoc's Bluestar (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Better Therapeutics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BigHealth (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Click Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Happify, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Naturalcycles Nordic AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuvoAir AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensyne Health plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations